This inventor holds 1 USPTO granted patent. Top assignee: Hammi Pharm Co., Ltd.. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000
Title: Hee-Chul Chang: Innovator in Pharmaceutical Composition
Introduction
Hee-Chul Chang is a notable inventor based in Goyang, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid dispersants for drug formulations. His work focuses on enhancing the bioavailability and stability of medications, which is crucial for effective treatment.
Latest Patents
Hee-Chul Chang holds a patent for a non-crystalline cefuroxime axetil solid dispersant. This innovative solid dispersant is prepared through a specific process that involves dissolving cefuroxime axetil and a surfactant in an organic solvent, suspending a water-insoluble inorganic carrier, and then drying the suspension to remove the organic solvent. The resulting product shows no absorption peak on a Differential Scanning Calorimetry scan, indicating its unique properties. This solid dispersant is particularly useful for the preparation of pharmaceutical compositions for oral administration, offering improved bioavailability and stability of cefuroxime axetil.
Career Highlights
Hee-Chul Chang is associated with Hammi Pharm Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing drug formulation techniques, making medications more effective for patients.
Collaborations
Hee-Chul Chang collaborates with Jong-Soo Woo, contributing to the development of new pharmaceutical solutions. Their partnership exemplifies the importance of teamwork in the field of innovation.
Conclusion
Hee-Chul Chang's contributions to pharmaceutical innovations highlight the critical role of inventors in enhancing drug formulations. His patent for a non-crystalline cefuroxime axetil solid dispersant showcases his commitment to improving medication efficacy and patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile